Literature DB >> 3652524

Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus.

M E Devey1, K Bleasdale, D A Isenberg.   

Abstract

Significant differences in both the affinity and IgG subclass of antibodies produced after immunization with tetanus toxoid have been demonstrated in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) compared to healthy controls. Patients with RA failed to show affinity maturation although they produced similar amounts of antibody to the controls. Some patients with SLE produced very high affinity antibodies although there was a wide spectrum of response. Antibodies to tetanus toxoid in controls were predominantly IgG1 and IgG4 but in RA and SLE there was either a restricted IgG1 response or a more general response in all the IgG subclasses. It is likely that these differences in response reflect the underlying disorders in immunoregulation present in patients with these diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652524      PMCID: PMC1542762     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  Cellular immunological aspects of rheumatoid arthritis.

Authors:  D T Yu; J B Peter
Journal:  Semin Arthritis Rheum       Date:  1974       Impact factor: 5.532

2.  The use of ammonium sulphate globulin precipitation for determination of affinity of anti-protein antibodies in mouse serum.

Authors:  M W Steward; R E Petty
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

3.  The immunopathological significance of the heterogeneity of antibody affinity.

Authors:  J F Soothill; M W Steward
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

4.  IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.

Authors:  M Mayumi; T Kuritani; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

Review 5.  Human IgG subclasses in health and disease. (A review). Part II.

Authors:  F Shakib; D R Stanworth
Journal:  Ric Clin Lab       Date:  1980 Oct-Dec

6.  Immunoglobulin G subclass of human antinuclear antibodies.

Authors:  T Tojo; G J Friou; H L Spiegelberg
Journal:  Clin Exp Immunol       Date:  1970-01       Impact factor: 4.330

7.  Immunoglobulin G (IgG) subclasses and human disease.

Authors:  V A Oxelius
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

8.  Mouse IgG antibodies have subclass associated affinity differences.

Authors:  H O Sarvas; I J Seppälä; T Tähtinen; F Péterfy; O Mäkelä
Journal:  Mol Immunol       Date:  1983-03       Impact factor: 4.407

9.  A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.

Authors:  F Hirata; E Schiffmann; K Venkatasubramanian; D Salomon; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.

Authors:  D M Mitchell; P Fitzharris; R A Knight; G C Schild; M L Snaith
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

View more
  11 in total

1.  Functional affinity of IgM rheumatoid factor in patients with rheumatoid arthritis and other autoimmune diseases.

Authors:  S Rath; D N Hogben; M E Devey
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

Review 2.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

Review 3.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

4.  Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture.

Authors:  P Bird; J E Calvert; H Mitchison; N R Ling; M Bassendine; O F James
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 5.  Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.

Authors:  Despoina Papadopoulou; Nikolaos V Sipsas
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

6.  The gut as an inductive site for synovial and extra-articular immune responses in rheumatoid arthritis.

Authors:  C Trollmo; C Sollerman; H Carlsten; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

Review 7.  Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Authors:  Johanna Westra; Christien Rondaan; Sander van Assen; Marc Bijl
Journal:  Nat Rev Rheumatol       Date:  2014-12-09       Impact factor: 20.543

8.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 9.  The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

Authors:  Yu Bin Seo; Su Jin Moon; Chan Hong Jeon; Joon Young Song; Yoon Kyoung Sung; Su Jin Jeong; Ki Tae Kwon; Eu Suk Kim; Jae Hoon Kim; Hyoun Ah Kim; Dong Jin Park; Sung Hoon Park; Jin Kyun Park; Joong Kyong Ahn; Ji Seon Oh; Jae Won Yun; Joo Hyun Lee; Hee Young Lee; Min Joo Choi; Won Suk Choi; Young Hwa Choi; Jung Hyun Choi; Jung Yeon Heo; Hee Jin Cheong; Shin Seok Lee
Journal:  Infect Chemother       Date:  2020-06

10.  Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.

Authors:  Caitlyn L Holmes; Chloe G Peyton; Amy M Bier; Tobias Z Donlon; Fauzia Osman; Christie M Bartels; Miriam A Shelef
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.